In the male Drosophila, the X chromosome is transcriptionally upregulated to achieve dosage compensation, in a process that depends on association of the MSL proteins with the X chromosome. A role for non-coding RNAs has been suggested in recent studies. The roX1 and roX2 RNAs are male-specific, non-coding RNAs that are produced by, and also found associated with, the dosage-compensated male X chromosome. Whether roX RNAs are physically part of the MSL complex has not been resolved.
Background
The process of dosage compensation equalizes the amount of products encoded by X-linked genes in males (XY or XO) and females (XX). Mammals, flies and nematodes have evolved dramatically different mechanisms to cope with chromosomal differences between the sexes (reviewed in [1] [2] [3] ). A unifying theme, however, is that remodeling chromatin architecture is likely to play a major role in each case. Two distinct mechanisms of dosage compensation have been postulated to operate in Drosophila (reviewed in [4] ). In the predominant pathway, five known proteins are thought to assemble into a large complex, which binds to hundreds of sites along the male X chromosome (reviewed in [3] ). These are collectively called the MSL proteins for their male-specific lethal phenotype when mutant. An important insight into the molecular mechanism of the MSL complex has come from the observation that the male X chromosome is also enriched for a specific isoform of histone H4 acetylated at Lys16 [5] . This site-specific histone acetylation is lost if males are mutant for any of the msl genes [6, 7] . A recently discovered MSL protein, Mof, has sequence similarity to known acetyltransferases, reinforcing the view that covalent modification of nucleosomes is a critical function of the MSL complex [7] .
Further hints of chromatin modifications come from the finding that the JIL-1 protein kinase is enriched along the male X chromosome in a pattern similar to the MSL complex and displays histone H3 kinase activity in vitro [8] .
How the MSL complex specifically recognizes the X chromosome has been a long-standing question. Recently, we proposed that Msl1 and Msl2 together recognize 30-40 chromatin entry sites, distributed along the length of the X chromosome, where they recruit the other MSL proteins [9] . Only two chromatin entry sites have been characterized to date, and they are the genes that encode roX1 and roX2 (RNA on X) RNAs, which are male-specific RNAs lacking significant open reading frames [9] [10] [11] . The roX RNAs colocalize with the MSL proteins along the length of the X chromosome [11, 12] . Individually, roX RNAs do not appear essential for MSL complex assembly on the X chromosome, but assembly of the complex is delayed or abolished when both RNAs are removed. This conclusion is based on analysis of embryos carrying an insertional mutation in roX1 and a large deletion removing many genes including roX2 [12] . Here, we test the idea that roX RNAs physically associate with MSL complexes by immunoprecipitation studies, and by analyzing roX RNA localization and stability in the presence and absence of complete MSL complexes.
We also address the question of how the action of MSL complexes is normally limited to genes on the X chromosome. Recently, we proposed that the 30-40 chromatin entry sites (including the roX1 and roX2 genes) are not only assembly sites for MSL complexes but are also nucleation sites for spreading along the chromosome in cis to dosage-compensate flanking genes, which themselves may have no X-specific features [9] . The evidence for this model rests on analysis of the roX1 transgene, which attracts MSL complexes and roX2 RNA to autosomal insertion sites, where the complex can spread long distances into flanking chromatin that was never before dosage compensated. We perform a critical test of this model, by determining whether a roX2 transgene can also establish a nucleation site for MSL spreading into flanking autosomal chromatin.
Results

Epigenetic spreading of MSL complexes from a roX2 transgene into flanking chromatin
Wild-type males have complete MSL complexes bound to hundreds of bands along the X chromosome in a highly reproducible pattern where they mediate hypertranscription. Genetic analysis of debilitated MSL complexes lacking either Mle, Msl3 or Mof subunits, or containing enzymatically dead Mof acetyltransferase or Mle helicase, has shown that partial MSL complexes can bind to only ~35 bands, named chromatin entry sites (formerly called high-affinity sites [9, [13] [14] [15] [16] ). Recently, we proposed that these sites direct dosage compensation to the X chromosome by serving as sites of assembly and subsequent spreading of the MSL complex into flanking chromatin in cis [9] . Previously, we identified roX2 as a chromatin entry site based on the ability of roX2 transgenes to attract the MSL complex to autosomal insertion sites, even in the absence of Msl3. To test whether roX2 could also support spreading of MSL complexes into flanking autosomes, we created multiple lines of transgenic larvae carrying genomic roX2 transgenes. We found that the roX2 chromatin entry site also supported variable spreading of MSL complexes into flanking chromatin ( Figure 1 ). The spreading displayed the same characteristics as previously reported for a roX1 transgene: bidirectionality, dependence on insertion site, and substantial variability even from nucleus to nucleus in Research Paper Non-coding roX RNAs on the X chromosome Meller et al. 137
Figure 1
The MSL complex spreads from autosomal roX2 transgenes. the same animal. These results strongly support the idea that most or all chromatin entry sites will act as nucleation points for MSL spreading in cis.
The roX RNAs are dependent on the MSL complex for stability To determine whether the roX RNAs and MSL proteins are associated in the same binding pattern on the X chromosome, we adapted the immunostaining protocol to allow detection of roX RNAs by in situ hybridization to spread polytene chromosomes. We found that the MSL proteins, roX1 and roX2 RNAs are precisely colocalized along the male polytene X chromosome (Figure 2 ), consistent with previous results based on whole-mount preparations [11, 12] . In addition, we consistently detected a subtle enrichment for roX1 RNA in several bands surrounding its site of synthesis (Figure 2a ,c, arrowhead at cytological position 3F).
In previous work, MSL proteins were found at decreased levels when they were unable to assemble into a wildtype complex [13, 17, 18] . Therefore, we asked whether roX RNAs might exhibit the same behavior, indicative of a requirement for complex assembly for their integrity. We expressed roX1 RNA constitutively from an H83roX1 transgene and determined whether roX1 RNA could accumulate and perhaps even associate with the X chromosomes in females, which lack MSL complexes. We found that ectopic roX1 RNA failed to bind the X chromosome in females as assayed by in situ hybridization (Figure 3d,g ). The Hsp83 promoter was active in females, as RNA expressed from H83roX1 was detected as a single band of hybridization at the transgene insertion site on an autosome (Figure 3g , arrowhead). Examination of whole mounts showed that the RNA did not accumulate anywhere within the female nuclei except at its site of synthesis (Figure 3d , arrowhead). Our in situ hybridizations may not have detected female RNA that was more dispersed throughout the cell, so we performed Northern analysis, which indicated that the roX1 RNA synthesized by the transgene was stable in males but failed to accumulate to high levels in females ( Figure 3e , lane 5). To determine whether the roX1 RNA produced from the H83roX1 transgene could be stabilized by the presence of the MSL complex, we assayed its behavior in males lacking endogenous roX1, or females that form MSL complexes as a result of ectopic expression of Msl2 [19] . We found that transgenic roX1 RNA associated with the X chromosome in males and in Msl2-expressing females ( Figure 3c ,f,h). Thus, roX1 RNA is dependent on the MSL complex for its stability. We also ectopically expressed the roX2 RNA in females, under control of the heat shock inducible Hsp70 promoter. Similar to the results from roX1 transgenic females, when roX2 RNA was ectopically expressed in females, only the site of nascent RNA production was evident (Figure 3i, arrowhead) . As the transgenic RNA was indistinguishable from endogenous roX2 RNA and we lack a roX2 mutant, we could not determine whether the RNA expressed in females from the H70roX2 transgene would be stabilized and associate with the X chromosome if the MSL complex were provided. The lack of X chromosome staining after induction of the Hsp70 promoter by heat shock was, however, consistent with our transgenic roX1 results, suggesting that the MSL proteins play a positive role in roX RNA stabilization, possibly through direct physical interaction.
The roX1 cDNA used in our analysis lacked approximately 300 nucleotides of 5′ transcribed roX1 sequence (data not shown), and yet produced RNA that could bind the X chromosome like wild-type roX1 RNA. Therefore, we further subdivided roX1 to determine whether the ability to bind the X chromosome was confined to the 5′ one-third, or 3′ two-thirds of the RNA. The truncated RNAs were produced using subfragments of the fulllength sequence under the control of the Hsp83 promoter (H83-5′roX1 and H83-3′roX1). We found that neither the 5′ nor the 3′ RNA was stable, even in males (Figure 4a,b) . Transgenic animals carrying both constructs were obtained by genetic crosses, but the separate pieces of RNA were unable to reassemble into stable complexes on the X chromosome (Figure 4c,d) . We conclude that roX synthesis, assembly and stability are likely to be tightly coupled. Without proper assembly, segments of roX RNA are targets for efficient destruction.
Ordered assembly of roX RNAs
The idea that the MSL complex assembles at chromatin entry sites rests on the observation that these are the only places partial MSL complexes bind when one subunit is removed by mutation. Therefore, we determined whether roX RNAs might also be associated with these partial complexes in the absence of spreading into flanking chromatin. To visualize chromatin entry sites, we used females that ectopically express Msl2 but are mutant for msl3 or mle. They assemble partial MSL complexes at the same sites as dying mutant males, but are viable and produce excellent polytene chromosomes (Figure 5a,b,e,f) . Surprisingly, we found a difference in the localization of roX1 and roX2 RNAs in msl3 mutants. Although roX1 RNA was detected only at cytological position 3F, the site of its synthesis, roX2 was consistently seen at many chromatin entry sites including 3F (Figure 5c,d ). This result suggests that roX2 may assemble first into partial MSL complexes and then be exported to other chromatin entry sites. These roX2-containing complexes may subsequently acquire a second roX RNA species (such as roX1) or be present in distinct complexes from roX1.
When we examined mle mutants for localization of roX RNAs, we found that roX2 RNA was no longer able to move to other chromatin entry sites, but was only detected at its site of synthesis, like roX1 (Figure 5g,h ). This demonstrates that the Mle helicase plays an early role, perhaps in packaging roX2 RNA into growing MSL complexes. Blocking assembly at this point prevents roX2 RNA from reaching other chromatin entry sites.
To further test the idea that roX2 assembly may occur at an earlier step than roX1, we determined whether roX2 RNA assembled correctly in the absence of roX1. We found that roX2 RNA is localized to the male X chromosome in the absence of roX1, with no apparent perturbation of its staining pattern (data not shown). We conclude that roX2 RNA, like the MSL protein complex [11] , is independent of roX1 for localization on the X chromosome. The roX2 RNA coimmunoprecipitates with MSL complexes MSL complexes can be immunoprecipitated from Schneider SL2 tissue-culture cells, which exhibit male-like X chromosomal MSL complex and histone H4Ac16 by immunostaining [20] . Therefore, we performed reverse transcription (RT)-PCR analyses to determine whether roX RNA could be coprecipitated with MSL complexes from SL2 cell extracts. We focused on roX2 because our genetic experiments predicted that it may be included at an early step in MSL complex assembly. RT-PCR products were first confirmed from male larval total RNA, SL2 cell total RNA, and SL2 cell protein lysates ( Figure 6A ), using primers flanking an intron of 141 bp [10] . Surprisingly, a smaller RNA with a 270 bp intron removed was the predominant product detected in both male larvae and SL2 cell total RNA. The intron encompasses the 141 bp intron and utilizes the same 3′ splice site (Figure 6b ). The spliced roX2 RNA was detected in immunoprecipitates from SL2 cells using anti-Msl1 and anti-Mle antibodies (Figure 6a, lanes 5,7) , but not with pre-immune sera or in the absence of antibodies (Figure 6a, lanes 6,8,9 ). We conclude that the MSL proteins are physically associated with the spliced form of roX2 RNA
Discussion
Until recently, it had been assumed that X-chromosomespecific cis-acting sequences would be associated with most genes bound by the MSL proteins. However, studies of roX1 suggested that, if provided with a chromatin entry site (a roX1 transgene), the MSL complex could be attracted in cis to genes on autosomes that were never before dosage-compensated. The complex could not normally gain access to the autosomes in wild-type males because the MSL chromatin entry sites are found only on the X chromosome. Here, we have shown that a roX2 transgene can also function as a chromatin entry site for spreading of MSL complexes into autosomal chromatin, fulfilling a key prediction of our model for X chromosome recognition by the MSL complex.
In addition to roX genes functioning as chromatin entry sites, it is thought that the RNAs themselves may play roles in MSL complex assembly or function on the X chromosome. Although large ribonucleoprotein machines are well known in the form of ribosomes, spliceosomes and telomerases, RNAs have not been considered important factors in transcriptional regulation. There have been recent reports, however, of transcriptional control by noncoding RNAs in several diverse systems [21, 22] . A prominent example is the Xist RNA, which has been shown to play a central role in silencing most of the genes along one of the two X chromosomes in mammals [23] [24] [25] [26] . Another example is SRA, a novel non-coding RNA discovered as a coactivator of steroid hormone receptors [27] . Individually, roX RNAs do not appear essential for MSL complex assembly on the X chromosome, but the phenotype of mutant embryos that lack roX1, roX2 and an unknown number of neighboring genes suggests that assembly of the MSL complex is delayed or abolished when both RNAs are removed [12] .
Our data are consistent with assembly of roX RNAs into MSL complexes. First, roX2 RNA can be immunoprecipitated from male tissue-culture cells, using anti-Msl1 or anti-Mle antibodies. Second, we have shown that the roX RNAs are highly unstable in the absence of MSL proteins even if their synthesis is driven by a strong constitutive or inducible promoter. Third, movement of roX2 RNA from its site of synthesis to other chromatin entry sites requires Mle helicase. These observations are most easily understood if the MSL proteins physically contact the roX RNAs, protecting them from cytoplasmic export or degradation and targeting them instead to the X chromosome.
One clear difference between roX1 and roX2 RNAs is that roX2 RNA can travel to ~35 other chromatin entry sites along the X chromosome in the absence of Msl3. Maturation of the complex is thought to take place at these sites and then to initiate spreading into flanking chromatin. In the same nuclei lacking Msl3 protein, roX1 RNA is found only at its site of transcription. This suggests that the protein and RNA components of the MSL complex may assemble in a stepwise manner at several sites, and that roX2 may play a role in early events (Figure 7) .
In previous work, we compared the binding sites for partial MSL complexes that lacked either the Msl3 protein or the Mle helicase [14] . The two different kinds of incomplete complexes bound nearly identical sets of chromatin entry sites in msl3 and mle mutants. A notable exception, however, was the 10C chromatin entry site, now known to be the roX2 gene. Partial MSL complexes lacking Msl3 bound 10C very well, but partial complexes lacking the Mle helicase did not. With improved staining methods, we can now sometimes detect faint MSL complexes at 10C in mle mutants (Figure 5f ). Nevertheless, while the site at 10C is among the strongest in msl3 mutants (Figure 5b) , it is one of the weakest sites in mle mutants (Figure 5f ). Thus, assembly of MSL proteins at roX2 may be particularly dependent on the Mle helicase. The placement of Mle early in the pathway to MSL complex assembly is consistent with the results of Gu et al. [16] based on studies of X chromosome association of the Mof acetyltransferase. Perhaps the first MSL subunits assemble with nascent roX2 RNA in a process requiring the Mle helicase to fold the RNA correctly ( Figure 7 ). Only after maturation is completed by the addition of more MSL proteins, perhaps other RNAs, and the activation of the Mof histone acetyltransferase [16] , is the MSL complex able to locate and act on its many target genes along the male X chromosome.
Conclusions
Our results support three interrelated roles for roX genes in dosage compensation: first, to produce RNA components of the MSL complex; second, to provide sites for complex assembly and, third, to mark the X chromosome for dosage compensation by acting as nucleation sites for spreading the MSL complex in cis to surrounding genes. We have presented a model for an ordered pathway of MSL-roX assembly, in which roX2 RNA joins partial MSL complexes at an early step and is exported to other chromatin entry sites in a process dependent on the Mle were generated with 30 cycles of PCR and subsequently diluted 100-1000-fold. Samples in lanes 5-9 were generated with 20 cycles of PCR. All samples were run on the same gel but lanes 1-4 were exposed for 2 h and lanes 5-9 for 11 h. (b) The intron size and the location of roX2 primers (arrows). This intron sequence was confirmed by direct sequencing of the spliced product from male larvae. helicase. The roX2-containing complexes may complete assembly at other chromatin entry sites, perhaps by acquiring a second roX RNA species (such as roX1). Only mature complexes are functional to spread and dosage compensate flanking genes on the X chromosome.
Materials and methods
Drosophila stocks and germline transformation
Larvae and flies were raised on standard cornmeal-yeast-agar-molasses medium containing propionic acid. P-element constructs were microinjected into y w; P[∆2-3] Ki/+ embryos that contain a stable source of P transposase [28] . The roX1 MB710 mutation and the roX1 ex6 deletion were reported in Meller et al. [11] . All mutants not specifically mentioned are described in Flybase (http://flybase.bio.indiana.edu/).
Transgene construction
The genomic roX2 transgene contained a 4 kb NotI fragment inserted into pCaSpeR 3. The transgenes expressing roX1 under control of the Hsp83 promoter each contained an EcoRI fragment from a roX1 cDNA [11] , inserted in the 'sense' direction into the EcoRI site of pCaSpeR-hs83T3. Plasmid pCaSpeR-hs83T3 is a modified version of pCaSpeR HS83 [29] carrying a tra2 polyadenylation signal (a 450 bp PstI fragment) inserted into the PstI site of the vector. H83roX1 contained a 3.3 kb EcoRI fragment from cDNA roX1-c20 inserted into pCaSpeRh83T3. H83-5′roX1 contained a 908 bp EcoRI fragment (bp 235-1143 of cDNA roX1-c3, numbering from Meller et al. [11] ), while H83-3′roX1 contained a 2.5 kb EcoRI fragment of roX1-c3 (bp 1143-3695) inserted into pCaSpeR-h83T3. A complete roX1-c3 cDNA, like roX1-c20, was capable of producing roX1 RNA that bound the X chromosome in trans (data not shown). The roX1 transgenes were assayed for the ability to produce roX1 RNA that bound the X chromosome in both roX1 MB710 and roX1 ex6 mutants, with identical results. The H70roX2 transgene, expressing cDNA roX2-78.13 [10] under the control of the Hsp70 promoter, contained a BamHI-StyI fragment (1212 bp) ligated into the BglII and XbaI sites of vector pCaSpeR-hs [30] .
Polytene chromosome immunostaining
Immunofluorescence using anti-MSL antibodies to stain polytene chromosomes was as described previously [9] .
In situ hybridizations
Whole-mount RNA in situ hybridizations were performed as described in Meller et al. [11] . In situ hybridization of polytene chromosome spreads was as follows. Larvae were grown at 18°C in uncrowded vials on standard cornmeal molasses food. Larvae were dissected in PBS, 4% formaldehyde, 1% Triton-X100, and fixed 45 sec. The fixative was replaced with 50% acetic acid, 4% formaldehyde for 2 min and then the glands were placed in lactoacetic acid (lactic acid: water: acetic acid; 1:2:3) and spread under a siliconized coverslip. The slides were frozen in liquid nitrogen, the coverslips removed and the tissue dehydrated in ethanol for 30 min, air dried, rehydrated in 70% and 30% ethanol, and finally in PBT (PBS containing 0.1% Tween 20). The tissue was fixed again in 4% formaldehyde in PBT for 15 min, washed 3 × 5 min in PBT and then treated with proteinase K (20 µg/ml in PBT) for 5.5 min. Following two 2 min washes in glycine (2 mg/ml) and two washes in PBT, the slides were fixed in 4% formaldehyde for 10 min. After two 5 min PBT washes, the slides were prehybridized 3 h at 42°C in 50% formamide, 5× SSC, 5× Denhardt's solution, 500 µg/ml salmon sperm DNA, 250 µg/ml tRNA. The slides were treated with the same hybridization solution (6-10 µl) containing single-stranded antisense riboprobes (30-50 ng) labeled with either digoxygenin or biotin (Boehringer Mannheim). Following overnight hybridization at 42°C in a humid chamber, the slides were washed sequentially, for 20 min each, in 50% formamide, 5× SSC, 10 mM DTT (42°C), 2× SSC (42°C), 0.1× SSC (23°C), 1× PBT (23°C), and then blocked for 30 min in PBT containing 5 mg/ml BSA. In cases where both biotin and digoxygenin probes were used, the slides were treated with fluorescein-labeled avidin (Oncor) for 1 h at 37°C then washed in PBT 3 × 3 min. The slides were treated with anti-digoxygenin monoclonal antibody (Sigma) and biotinylated anti-avidin antibody (1:200, Oncor) for 1 h at 37°C, washed 3 × 3 min in PBT, and then treated with 1:200 digoxygenin-labeled anti-mouse F(ab')2 fragments (Boehringer Mannheim) at 37°C for 1 h followed by washes in PBT. The probes were visualized by treating with rhodamine-labeled anti-digoxygenin Fab fragments (1:200, Boehringer Mannheim) and fluorescein-labeled avidin at 4°C overnight. Following washes, the DNA was counterstained with 1 µg/ml DAPI and photographed under epifluorescence.
Double labeling for colocalization of roX RNAs and MSL protein
Chromosomes were spread, dehydrated and dried as above. The slides were hybridized with biotin-labeled riboprobes (1 µg/ml) in ChromaHyb 600 hybridization buffer (Quantum) at 60°C overnight. The slides were washed at 60°C in ChromaHyb wash (Quantum) diluted 1:80 for 3 min, 1:200 for 2 min, 1:80 for 30 sec, 1:400 three times for 30 sec each. The final wash was in PBT for 10 min at 23°C. The slides were blocked in PBT + 0.5% BSA 30 min at 23°C. The slides were treated in a humid chamber overnight at 4°C with affinity purified rabbit anti-Msl1 antibody (1:50) and fluorescein-labeled avidin (1:200), and washed 3 × 3 min in PBT. The slides were treated with biotinylated anti-avidin antibody for 1 h at 37°C, and washed 3 × 3 min in PBT. The RNA signal was detected with fluorescein-labeled avidin, and the MSL signal was visualized with Texas-Red-labeled goat anti-rabbit antibodies.
Northern blot analysis
Northerns were performed as described previously [31] using 5 µg polyA + adult RNA per lane and random-primed double-stranded roX1 cDNA20 as probe.
Immunoprecipitation and RT-PCR
Total RNA of male larvae and SL2 cells were isolated using TRIzol reagent (Life Technologies). The total protein lysates of SL2 cells were prepared by vortexing SL2 cells in extraction buffer [27] . Lysate containing 100 µg total protein was incubated with 3 µl rabbit polyclonal antibody or preimmunune sera for 35 min at 4°C followed by a 30 min incubation at 4°C with protein A-Sepharose pre-equilibrated with extract buffer. Beads were washed three times with five volumes of extract buffer and incubated for 20 min at 37°C with RNase-free DNaseI (Boehringer Mannheim). RNA was isolated by phenol-chloroform extraction and ethanol precipitation. First-strand cDNA was synthesized using SuperScriptII reverse transcriptase (Life Technologies). Ten percent (2 µl) of the reaction was used in a 50 µl PCR amplification by using 0.2 µM of rox2-specific primers (2-1: 5′-TTGGCATTTT GCTCTTGTTTTTCTC-3′ and 2-2: 5′-CGTTACTCTTGCTTGATTTTGCTTCG-3′; see Figure 6 ). PCR was performed as follows: 4 min at 94°C, 20 or 30 cycles of 1 min at 94°C, 1 min at 60°C, 1 min at 72°C, and 10 min at 72°C. RT-PCR products were electrophoresed, blotted and hybridized with a probe corresponding to the sequenced roX2 PCR product from male larvae.
